Camidanlumab tesirine | m-entrepreneurship.com

Product Name :
Camidanlumab tesirine

Search keywords :
Camidanlumab

drugId :
null

Target Vo:
DNA

Target Vo Short Name :
DNA

Moa_Name:
DNA cross linking agents

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Adc Therapeutics Sa

Active Company_Name :
Adc Therapeutics Sa

Active Indication_Name:
Hodgkin Disease

In Active Indication_Name:
Urinary Bladder Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Dnmt3a Rabbit mAb Autophagy
Phospho-IRF3 (Ser386) Antibody Cancer
Insulin Receptor Beta Antibody: Insulin Receptor Beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Insulin Receptor Beta. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts